Taselisib
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Taselisib, covering 2018-05-21 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer [Phase 1]